AstraZeneca wins $107 million drug patent verdict overturned in US
Por Blake Brittain Aug 14 (Reuters) – AstraZeneca persuaded a Delaware federal judge on Wednesday to overturn a jury ruling that found the company must pay $107.5 million for infringing cancer drug patents owned by Pfizer unit Wyeth. U.S. District Judge Matthew Kennelly ruled that two patents that Pfizer said AstraZeneca infringed with its blockbuster … Read more